Aveanna Healthcare beats Q4 estimates, shares rise over 5%

Published 13/03/2025, 11:40
Aveanna Healthcare beats Q4 estimates, shares rise over 5%

ATLANTA -On Thursday, Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) reported better-than-expected fourth quarter results and provided strong 2025 guidance.

The company’s shares were up 5.35% in premarket trading following the release.

The home healthcare provider posted adjusted earnings per share of $0.05, beating analyst estimates of breakeven. Revenue came in at $519.9 million, surpassing expectations of $499.07 million and representing an 8.6% increase from the prior year period.

"Our fourth quarter results reflect an exceptional year of transformation at Aveanna," said CEO Jeff Shaner. He noted revenue and adjusted EBITDA growth of 8.6% and 42.8% respectively compared to Q4 2023.

For the full year 2024, Aveanna generated over $2 billion in revenue and adjusted EBITDA exceeding $183 million.

Looking ahead, the company provided robust guidance for fiscal 2025, projecting revenue between $2.10-$2.12 billion. This outlook is in line with analyst expectations of $2.11 billion.

Aveanna’s gross margin improved to 33.0% in Q4 from 31.0% a year ago. The company also reported net income of $29.2 million for the quarter, compared to a net loss of $25.7 million in Q4 2023.

CFO Matt Buckhalter highlighted the company’s strategic cost reductions and success of its preferred payor strategy as key drivers of profitability improvement.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.